Closed
SectorHealthcare
10.09 2.64
24h
Min
9.75
Max
10.13
Income | 212M 25M |
---|---|
Sales | 4.5M 9M |
EPS | -0.199 |
Profit margin | 280.018 |
Employees | 908 |
EBITDA | -52M -274M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +349.24% upside |
Market Cap | 7.4B |
---|---|
Previous open | 7.45 |
Previous close | 10.09 |
By Acuity
50%
50%
180 / 386 Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 44.25 USD 349.24%
High 129 USD
Low 12 USD
Based on 6 Wall Street analysts offering 12 month price targets forRoivant Sciences Ltd - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$